ALISO VIEJO, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Oceanside Pharmaceuticals, part of Valeant Pharmaceuticals International , today announced that it has now launched chlordiazepoxide hydrochloride and clidinium bromide, an authorized generic (AG) version of Librax(R). Oceanside has received its first orders and expects to be a significant player in the Librax(R) generic market.
Valeant Pharmaceuticals International is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at www.valeant.com.
CONTACT: Laurie W. Little of Valeant Pharmaceuticals, +1-949-461-6002,
Web site: http://www.valeant.com/